Macquarie University Hospital

North Ryde, New South Wales 2109

1 studies enrolling now · 6 studies all time

What they study most

Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Breast Cancer, Breast Carcinoma, Breast Tumor, Cancer of Breast, Cancer of Ovary, Cancer of Pancreas, Cancer of Prostate, Cancer of the Breast, Cancer of the Ovary, Cancer of the Pancreas

Studies at this site

• A Study of DM005 in Patients With Advanced Solid Tumors — Recruiting now
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) — Completed
• NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors — Stopped early
• SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma — Stopped early
• CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma — Completed